CD8A and cancer: In chronic infections, cancers, and autoimmune diseases, mitochondrial abnormalities are often observed, including reduced mitochondrial biogenesis, impaired OXPHOS, and increased mitochondrial reactive oxygen species (ROS) production.[6] These defects contribute to the exhaustion and dysfunction of CD8+ T cells, impairing their ability to mount effective immune responses.